DUBLIN, November 9, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "US Product Portfolio for Surgical Navigation and Robotics Systems 2017 - MedFolio" report to their offering.
The shift from open cavity procedures to minimally invasive procedures has already occurred within the United States. For hospitals to attract top talent, they must be equipped with the latest in high-tech equipment and facilities in order to increase efficiency for the surgeon. Incorporating surgical navigation and robotic systems into operating rooms helps institutions promote themselves as industry leaders. Surgical navigation is a more established technology which has become the standard of care in neurosurgery, with adoption increasing in other segments.
In addition, the growth of the surgical robotics market is expected to broaden the variety of procedures which can be done using a minimally invasive approach while reinforcing existing clinical benefits. For many procedures, the use of an IGS or robotic system increases the duration of the operation. Facilities and surgeons will therefore lose money as they are forced to schedule fewer procedures. This delay has decreased with newer models; however, any increase in time may reduce the number of operations that can be scheduled in a facility.
This negatively impacts both surgeons and facilities, and can make potential clients less willing to pay the high costs associated with robotics systems. Surgical navigation systems are often marketed by implant companies and bundled with other products, while robotics companies have traditionally been smaller and focused on a narrower range of technologies. However, partnerships have led to a series of acquisitions of smaller robotics companies by larger, more established medical device companies. Since the technologies can be considered competitors, this trend is expected to continue as robotic technology becomes more widely adopted and accepted.
Key Topics Covered:
1. Executive Summary
2. Disease Overview
2.1 Medical Conditions
2.1.1 Neurosurgery Conditions
2.1.2 Spinal Conditions
2.1.3 Ent Conditions
2.1.4 Orthopedic Conditions
2.1.5 Gynecological Conditions
2.1.6 Urological Conditions
2.1.7 Digestive Tract Conditions
2.1.8 Colorectal Conditions
3. Product Assessment
3.1 Robotic Assisted Surgery Product Portfolios
3.2 Surgical Navigation Product Portfolios
3.2.3 Spine Surgery
3.2.4 Ear, Nose, Throat Surgery
3.2.5 Orthopedic Surgery
3.3 Ras Regulatory Issues And Recalls
3.3.1 Accuray Inc.
3.3.2 Blue Belt Technologies
3.3.3 Hansen Medical Inc.
3.3.4 Intuitive Surgical
3.3.5 Mako Surgical/Stryker
3.3.6 Omnilife Science
3.4 Surgical Navigation Regulatory Issues And Recalls
3.5 Clinical Trials
3.6 Ras Clinical Trials
3.6.1 Accuray Inc.
3.6.2 Catheter Precision
3.6.3 Corindus Inc
3.6.4 Hansen Medical
3.6.5 Intuitive Surgical
3.6.6 Mako Surgical/Stryker
3.7 Surgical Navigation Clinical Trials
For more information about this report visit http://www.researchandmarkets.com/research/5xtfp6/us_product
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets